Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

BioNexus Gene Lab (BGLC) Non Operating Income (2024 - 2025)

Historic Non Operating Income for BioNexus Gene Lab (BGLC) over the last 2 years, with Q3 2025 value amounting to $107760.0.

  • BioNexus Gene Lab's Non Operating Income fell 7685.2% to $107760.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2024, which is 32640.32% up from last year.
  • As of Q3 2025, BioNexus Gene Lab's Non Operating Income stood at $107760.0, which was down 7685.2% from $209461.0 recorded in Q2 2025.
  • In the past 5 years, BioNexus Gene Lab's Non Operating Income ranged from a high of $730105.0 in Q2 2024 and a low of $91420.0 during Q1 2025